Yarrow Bioscience (YARW) Non-Current Deffered Revenue (2016 - 2018)

Yarrow Bioscience (YARW) has 3 years of Non-Current Deffered Revenue data on file, last reported at $6.3 million in Q1 2018.

• Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $6.3 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $6.3 million (changed N/A YoY) and the FY2017 annual result came in at $6.7 million, down 21.05% from the prior year.
• Non-Current Deffered Revenue declined to $6.3 million in Q1 2018, from $6.7 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $8.5 million in Q4 2016 to a low of $6.3 million in Q1 2018.
• A 3-year average of $7.2 million and a median of $6.7 million in 2017 frame the typical range for Non-Current Deffered Revenue.
• The widest YoY moves for Non-Current Deffered Revenue: up 21.05% in 2017, down 21.05% in 2017.
• Tracing YARW's Non-Current Deffered Revenue over 3 years: stood at $8.5 million in 2016, then retreated by 21.05% to $6.7 million in 2017, then slipped by 6.67% to $6.3 million in 2018.
• The last three Non-Current Deffered Revenue figures came in at $6.3 million (Q1 2018), $6.7 million (Q4 2017), and $8.5 million (Q4 2016), per Business Quant data.